Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients

BACKGROUND: End-stage renal disease yields susceptibility to both ischemia and bleeding. The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is not established in dialysis patients, who are usually excluded from randomized studies. Since recent studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seokwoo, Kim, Yaerim, Jo, Hyung Ah, Lee, Soojin, Kim, Mi-Sook, Yang, Bo Ram, Lee, Joongyub, Han, Seung Seok, Lee, Hajeong, Lee, Jung Pyo, Joo, Kwon Wook, Lim, Chun Soo, Kim, Yon Su, Kim, Dong Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577762/
https://www.ncbi.nlm.nih.gov/pubmed/33125004
http://dx.doi.org/10.1093/ckj/sfaa037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577762/
https://www.ncbi.nlm.nih.gov/pubmed/33125004
http://dx.doi.org/10.1093/ckj/sfaa037

Ejemplares similares